Evidence map›Paper›PMID 27510531›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2017

Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.

Stacey Dineen Rodenbeck, Chad A Zarse, Mikaela L McKenney-Drake, Rebecca S Bruning, Michael Sturek, Neal X Chen, Sharon M Moe

Open access · bronzeAbstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Intracellular CaJournal of cardiovascular translational research · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Phosphate-induced ORAI1 expression and store-operated CaJournal of molecular medicine (Berlin, Germany) · 2019
    Article
  11. Review
  12. Effect of metabolic syndrome and aging on CaExperimental gerontology · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stacey Dineen RodenbeckDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
Chad A ZarseDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Mikaela L McKenney-DrakeDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
Rebecca S BruningDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
Michael SturekDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
Neal X ChenDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Sharon M MoeDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · US

Funding

Training in Vascular Biology and MedicineT32HL079995 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARCH, KEITH LEONARD · 2005 to 2014
$2.2M
Bisphosphonates in the treatment of chronic kidney disease-mineral bone diseaseR01AR058005 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M · 2010 to 2014
$1.6M
BLRD VA I01 BX001471NHLBI NIH HHS T32 HL079995NIAMS NIH HHS R01 AR058005
6 · The paper itself

Abstract

Background: Vascular smooth muscle cells (VSMCs) exhibit phenotypic plasticity, promoting vascular calcification and increasing cardiovascular risk. Changes in VSMC intracellular calcium ([Ca 2+ ] i ) are a major determinant of plasticity, but little is known about changes in [Ca 2+ ] i in chronic kidney disease (CKD). We have previously demonstrated such plasticity in aortas from our rat model of CKD and therefore sought to examine changes in [Ca 2+ ] i during CKD progression. Materials and Methods: We examined freshly isolated VSMCs from aortas of normal rats, Cy/+ rats (CKD) with early and advanced CKD, and advanced CKD rats treated without and with 3% calcium gluconate (CKD + Ca 2+ ) to lower parathyroid hormone (PTH) levels. [Ca 2+ ] i was measured with fura-2. Results: Cy/+ rats developed progressive CKD, as assessed by plasma levels of blood urea nitrogen, calcium, phosphorus, parathyroid hormone and fibroblast growth factor 23. VSMCs isolated from rats with CKD demonstrated biphasic alterations in resting [Ca 2+ ] i : VSMCs from rats with early CKD exhibited reduced resting [Ca 2+ ] i , while VSMCs from rats with advanced CKD exhibited elevated resting [Ca 2+ ] i . Caffeine-induced sarcoplasmic reticulum (SR) Ca 2+ store release was modestly increased in early CKD and was more drastically increased in advanced CKD. The advanced CKD elevation in SR Ca 2+ store release was associated with a significant increase in the activity of the sarco-endoplasmic reticulum Ca 2+ ATPase (SERCA); however, SERCA2a protein expression was decreased in advanced CKD. Following SR Ca 2+ store release, recovery of [Ca 2+ ] i in the presence of caffeine and extracellular Ca 2+ was attenuated in VSMCs from rats with advanced CKD. This impairment, together with reductions in expression of the Na + /Ca 2+ exchanger, suggest a reduction in Ca 2+ extrusion capability. Finally, store-operated Ca 2+ entry (SOCE) was assessed following SR Ca 2+ store depletion. Ca 2+ entry during recovery from caffeine-induced SR Ca 2+ store release was elevated in advanced CKD, suggesting a role for exacerbated SOCE with progressing CKD. Conclusions: With progressive CKD in the Cy/+ rat there is increased resting [Ca 2+ ] i in VSMCs due, in part, to increased SOCE and impaired calcium extrusion from the cell. Such changes may predispose VSMCs to phenotypic changes that are a prerequisite to calcification.

Indexed as

AnimalsAortaCaffeineCalciumCalcium GluconateCardiovascular DiseasesCells, CulturedDisease Models, AnimalDisease ProgressionIn Vitro TechniquesMaleMuscle, Smooth, VascularMyocytes, Smooth MusclePurinergic P1 Receptor AntagonistsRatsRenal Insufficiency, ChronicCaffeineCalciumCalcium GluconatePurinergic P1 Receptor AntagonistsSarcoplasmic Reticulum Calcium-Transporting ATPasesSodium-Calcium Exchangercalcium signalingcell phenotypechronic kidney diseaserat modelvascular smooth muscle cells

Identifiers

PMID27510531
PMCPMC5837609
OpenAlexW2493718871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.